Compare Boston Scientific Corporation (BSX) vs Tesla, Inc. (TSLA) Price & Performance

Boston Scientific CorporationTrade

Tesla, Inc.Trade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Tesla, Inc. — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Tesla, Inc. trades at $334.36 (market cap $1.31T). The key difference: Tesla, Inc. is far larger — about 18.3× Boston Scientific Corporation's market cap. Which is the better fit depends on your goals.

	BSX	TSLA
Market Cap	$71.46B	$1.31T
Sector	Health	Consumer Cyclical
52-Week High	$108.14	$489.88
52-Week Low	$42.63	$298.16
Enterprise Value	$83.55B	$1.28T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

No Aura AI signal available yet.

Tesla, Inc.

Tesla (TSLA) trades at $330.87, up 0.7% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key resistance at $333 and support at $327, while fundamentals reveal high valuation multiples (P/E 306.37) and declining profit margins (net margin 3.67% in 2025). Recent news highlights regulatory approval for self-driving software in Europe and a potential cheaper EV launch, balancing near-term delivery misses with long-term innovation bets.

Tesla's outlook hinges on executing its pivot to AI and autonomy amid slowing auto growth. Investment opportunities lie in market leadership in self-driving technology and energy expansion, but risks include intense EV competition, execution challenges, and rich valuations that demand flawless growth. Wall Street remains divided, with a $393.87 consensus target suggesting upside if catalysts materialize.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BSX

Boston Scientific posts strong Q2 growth despite U.S. challenges, stock now valued attractively.Seeking Alpha · 1 day agoBullish Boston Scientific to present at Wells Fargo Healthcare Conference and report Q3 2026 results in OctoberPRNewsWire · 2 days agoNeutral View details →

TSLA

Humanoid robot boom drives huge memory demand, spotlighting Micron as key supplier amid tight DRAM supply.24/7 Wall Street · 21 hours agoBullish Unitree's $900M IPO oversubscribed 8,000x signals booming investor interest in physical AI robotics.24/7 Wall Street · 22 hours agoBullish Nio shares drop 5% after BlackRock reduces stake despite strong delivery growth.24/7 Wall Street · 22 hours agoBearish View details →

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.